Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
topic_facet:"Recruitment Status: Withdrawn"
topic_facet:"Carcinoma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22&filter%5B%5D=topic_facet%3A%22Carcinoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22&filter%5B%5D=topic_facet%3A%22Carcinoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22&filter%5B%5D=topic_facet%3A%22Carcinoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (51)
1
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer : A Phase 1b, Open-Label, Single-Arm Dose-Expansion Study of IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, in Combination With Nivolumab in Patients With Primary PD-1 Inhibitor Resistant Metastatic or Locally Incurable, Recurrent HNSCC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin : Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers : A Phase Ib Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers (PANTHEoN)
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
4
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer : ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
5
Vaccine Response With NT-I7 : A Phase 1/1b Study of Enhancement of Immune Reconstitution and Vaccine Responses With Administration of Recombinant Human IL-7-hyFc (NT-I7) in Older Subjects Following Chemotherapy
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
6
Cemiplimab/Peg-Interferon-α in Advanced CSCC : Cemiplimab/PEG-Interferon-α Combination for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
7
sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer : A First-in-Human Phase I Study of Intravesical sEphB4-HSA in Patients With "BCG-Unresponsive" Bladder Carcinoma In Situ (CIS), Completely Resected High Grade Ta/T1, to Establish the Maximum Tolerated Dose (MTD) or Recommended Phase II Dose (RP2D)
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
8
Implantable Microdevice for TNBC - Pilot Study : Pilot Study of an Implantable Microdevice to Evaluate Drug Responses in Situ in Early-stage Triple-negative Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
9
RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC : A Phase 1 First-in-Human, Drug-dose Escalation Study of RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced Cutaneous Squamous Cell Carcinoma or With Head and Neck Squamous Cell Carcinoma
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
10
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy : A Phase I Dose Escalation Study of the mTOR Inhibitor Everolimus (RAD001) and Erlotinib Concurrently With Radiation Therapy in the Re-Irradiation Setting for Head and Neck Cancer
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1
Filter aufheben
Thema: Recruitment Status: Withdrawn
Filter aufheben
Thema: Carcinoma
Medienart
51
Aufsätze
51
E-Artikel
51
E-Ressourcen
Zeitschriftentitel
51
ClinicalTrials.gov
Thema
51
610
Carcinoma
Phase: Phase 1
Recruitment Status: Withdrawn
51
Study Type: Interventional
16
Carcinoma, Squamous Cell
12
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Ovarian Epithelial
8
Ovarian Neoplasms
7
Breast Neoplasms
7
Carcinoma, Hepatocellular
6
Neoplasms
4
Carcinoma, Renal Cell
4
Head and Neck Neoplasms
4
Peritoneal Neoplasms
3
Adenocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Fallopian Tube Neoplasms
3
Laryngeal Neoplasms
3
Lung Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
23
2020-
28
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
51
Englisch
Haven't found what you're looking for?
Wird geladen...